Amarin Corp Plc (AMRN)

[ggwpq]

STS posted this earlier :

"Jenkins pointed out the logistical difficulty of going back and re-visiting previous approvals. A system that required the agency to revisit every prior decision as science evolves and standards change would make the regulatory process impossibly cumbersome and burdensome on both the agency and sponsors of approved indications.”

The same Jenkins that Amarin is appealing to now!